SNY
Income statement / Annual
Last year (2023), Sanofi's total revenue was $43.07 B,
a decrease of 5.11% from the previous year.
In 2023, Sanofi's net income was $5.40 B.
See Sanofi’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$43.07 B
|
$45.39 B
|
$39.18 B
|
$37.37 B
|
$37.63 B
|
$35.68 B
|
$36.22 B
|
$34.70 B
|
$34.86 B
|
$32.00 B
|
| Cost of Revenue |
$16.57 B |
$13.70 B |
$12.26 B |
$12.16 B |
$11.98 B |
$11.44 B |
$11.61 B |
$10.70 B |
$10.92 B |
$10.23 B |
| Gross Profit |
$26.50 B |
$31.69 B |
$26.92 B |
$25.21 B |
$25.65 B |
$24.24 B |
$24.61 B |
$24.00 B |
$23.94 B |
$21.77 B |
| Gross Profit Ratio |
0.62 |
0.7 |
0.69 |
0.67 |
0.68 |
0.68 |
0.68 |
0.69 |
0.69 |
0.68 |
| Research and Development
Expenses |
$6.73 B
|
$6.71 B
|
$5.69 B
|
$5.53 B
|
$6.02 B
|
$5.89 B
|
$5.47 B
|
$5.17 B
|
$5.08 B
|
$4.67 B
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$1.00 M
|
$1.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$9.39 B
|
$9.88 B
|
$9.86 B
|
$10.07 B
|
$9.48 B
|
$9.38 B
|
$8.43 B
|
| Selling, General &
Administrative Expenses |
$10.59 B
|
$10.49 B
|
$9.56 B
|
$9.39 B
|
$9.88 B
|
$9.86 B
|
$10.07 B
|
$9.48 B
|
$9.38 B
|
$8.43 B
|
| Other Expenses |
$2.00 M |
-$370.00 M |
-$5.00 M |
$136.00 M |
$327.00 M |
$502.00 M |
-$215.00 M |
$211.00 M |
$2.35 B |
$2.32 B |
| Operating Expenses |
$17.32 B |
$19.81 B |
$17.77 B |
$17.32 B |
$18.47 B |
$17.99 B |
$17.41 B |
$16.47 B |
$16.81 B |
$15.03 B |
| Cost And Expenses |
$33.89 B |
$33.51 B |
$30.03 B |
$29.48 B |
$30.45 B |
$29.42 B |
$29.02 B |
$27.17 B |
$27.73 B |
$25.26 B |
| Interest Income |
$546.00 M |
$241.00 M |
$54.00 M |
$103.00 M |
$146.00 M |
$123.00 M |
$147.00 M |
$68.00 M |
$178.00 M |
$192.00 M |
| Interest Expense |
$1.09 B |
$472.00 M |
$403.00 M |
$434.00 M |
$465.00 M |
$495.00 M |
$420.00 M |
$924.00 M |
$559.00 M |
$598.00 M |
| Depreciation &
Amortization |
$3.78 B
|
$3.70 B
|
$3.13 B
|
$3.27 B
|
$3.75 B
|
$3.46 B
|
$3.15 B
|
$2.99 B
|
$4.28 B
|
$3.28 B
|
| EBITDA |
$12.96 B
|
$15.54 B
|
$12.56 B
|
$11.80 B
|
$15.12 B
|
$11.19 B
|
$10.82 B
|
$11.11 B
|
$11.59 B
|
$10.21 B
|
| EBITDA Ratio |
0.3 |
0.34 |
0.32 |
0.32 |
0.4 |
0.31 |
0.3 |
0.32 |
0.33 |
0.32 |
| Operating Income Ratio
|
0.21
|
0.23
|
0.21
|
0.38
|
0.08
|
0.13
|
0.16
|
0.19
|
0.16
|
0.19
|
| Total Other
Income/Expenses Net |
-$2.03 B
|
-$1.23 B
|
-$1.02 B
|
$6.22 B
|
-$4.13 B
|
-$1.51 B
|
-$1.40 B
|
-$995.00 M
|
-$1.51 B
|
-$676.00 M
|
| Income Before Tax |
$7.15 B |
$10.42 B |
$7.80 B |
$13.78 B |
$2.75 B |
$4.41 B |
$5.53 B |
$5.68 B |
$5.24 B |
$5.66 B |
| Income Before Tax Ratio
|
0.17
|
0.23
|
0.2
|
0.37
|
0.07
|
0.12
|
0.15
|
0.16
|
0.15
|
0.18
|
| Income Tax Expense |
$1.60 B |
$2.01 B |
$1.56 B |
$1.81 B |
$121.00 M |
$481.00 M |
$1.72 B |
$1.33 B |
$709.00 M |
$1.21 B |
| Net Income |
$5.40 B |
$8.37 B |
$6.22 B |
$12.29 B |
$2.75 B |
$4.31 B |
$8.42 B |
$4.71 B |
$4.29 B |
$4.39 B |
| Net Income Ratio |
0.13 |
0.18 |
0.16 |
0.33 |
0.07 |
0.12 |
0.23 |
0.14 |
0.12 |
0.14 |
| EPS |
2.15 |
3.35 |
2.49 |
4.91 |
1.1 |
1.73 |
3.35 |
1.83 |
1.64 |
1.67 |
| EPS Diluted |
2.15 |
3.33 |
2.48 |
4.88 |
1.1 |
1.72 |
3.32 |
1.82 |
1.63 |
1.65 |
| Weighted Average Shares
Out |
$2.50 B
|
$2.50 B
|
$2.51 B
|
$2.51 B
|
$2.50 B
|
$2.49 B
|
$2.51 B
|
$2.57 B
|
$2.61 B
|
$2.63 B
|
| Weighted Average Shares
Out Diluted |
$2.51 B
|
$2.51 B
|
$2.52 B
|
$2.52 B
|
$2.51 B
|
$2.51 B
|
$2.53 B
|
$2.59 B
|
$2.64 B
|
$2.66 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
